Keele, UK-based Biocomposites has reached a multi-year agreement with Zimmer Biomet to exclusively distribute genex Bone Graft Substitute in the United States with a new mixing system and new delivery options. genex has been updated for the U.S market to include a new closed-mixing system that could shorten preparation time and extend working time. The new bone graft substitute will also be provided with a more comprehensive set of delivery options to allow a surgeon to inject, mold, or prepare beads in accordance with their chosen technique, Biocomposites reported in a news release.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,